Experience
BioDelivery Sciences International, Inc. et al.
Chemo Research, SL et al.
Represented BioDelivery Sciences International and Arius Two in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic copies of Belbuca®.
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al., 1:19-cv-00444, D. Del., Judge Connolly
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al.
BioDelivery Sciences International, Inc. et al.
AbbVie Inc.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.
Aerin Medical Inc. et al.
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Zimmer Surgical, Inc. et al. v. Stryker Corporation et al.
Zimmer Surgical, Inc.
Shure Incorporated et al. v. ClearOne, Inc.
Shure Incorporated et al.
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
Novartis Gene Therapies, Inc. et al.
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
Duchesnay Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.